Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma

Nature Genetics

Volumn 43, Issue 5, 2011, Pages 455-458

  Kumar, Vinod ^a,b   Kato, Naoya ^a   Urabe, Yuji ^a   Takahashi, Atsushi ^b   Muroyama, Ryosuke ^a   Hosono, Naoya ^b   Otsuka, Motoyuki ^c   Tateishi, Ryosuke ^c   Omata, Masao ^c   Nakagawa, Hidewaki ^b   Koike, Kazuhiko ^c   Kamatani, Naoyuki ^b   Kubo, Michiaki ^b   Nakamura, Yusuke ^a,b   Matsuda, Koichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHROMOSOME 6P; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FLANKING REGION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPANESE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

HEPATITIS C VIRUS;

EID: 85027954267     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.809     Document Type: Article

References (40)

1. Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C J. Clin. Pharmacol. 44, 20-29 (2004).
2. Parkin, D.M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108 (2005).
3. Umemura, T., Ichijo, T., Yoshizawa, K., Tanaka, E. & Kiyosawa, K. Epidemiology of hepatocellular carcinoma in Japan. J. Gastroenterol. 44 (Suppl 19), 102-107 (2009).
4. Vong, S. & Bell, B.P. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 39, 476-483 (2004). (Pubitemid 38222189)
5. Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399-401 (2009).
6. Thomas, D.L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798-801 (2009).
7. Rauch, A. et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138, 1338-1345, 1345.e1-7 (2010).
8. Kamatani, Y. et al. A genome-wide association study identifes variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 41, 591-595 (2009).
9. Schütte, K., Bornschein, J. & Malfertheiner, P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig. Dis. 27, 80-92 (2009).
10. Tanaka, T. et al. Signifcance of specifc antibody assay for genotyping of hepatitis C virus. Hepatology 19, 1347-1353 (1994). (Pubitemid 24166452)
11. Tanaka, Y. et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat. Genet. 41, 1105-1109 (2009)
12. Anonymous. Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature 401, 921-923 (1999).
13. de Bakker, P.I. et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet. 38, 1166-1172 (2006). (Pubitemid 44470362)
14. Kuniholm, M.H. et al. Specifc human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology 51, 1514-1522 (2010).
15. Wang, J.H. et al. Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Virol. J. 6, 46 (2009).
16. Singh, R., Kaul, R., Kaul, A. & Khan, K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J. Gastroenterol. 13, 1770-1787 (2007). (Pubitemid 46706009)
17. Dixon, A.L. et al. A genome-wide association study of global gene expression. Nat Genet. 39, 1202-1207 (2007). (Pubitemid 47482680)
18. Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399-401 (2009).
19. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729 (1999).
20. Salih, H.R., Rammensee, H. & Steinle, A. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J. Immunol. 169, 4098-4102 (2002). (Pubitemid 35178177)
21. Waldhauer, I. et al. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 68, 6368-6376 (2008).
22. Jinushi, M. et al. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J. Hepatol. 43, 1013-1020 (2005). (Pubitemid 41627987)
23. Groh, V., Wu, J., Yee, C & Spies, T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419, 734-738 (2002). (Pubitemid 35177960)
24. Doubrovina, E.S. et al. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J. Immunol. 171, 6891-6899 (2003). (Pubitemid 37532125)
25. Kohga, K. et al. Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma. Cancer Sci. 99, 1643-1649 (2008).
26. Jinushi, M. et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer 104, 354-361 (2003). (Pubitemid 36249818)
27. Groh, V. et al. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96, 6879-6884 (1999). (Pubitemid 29274978)
28. Ota, M. et al. Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 49, 448-454 (1997). (Pubitemid 27207749)
29. Groh, V. et al. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol. 2, 255-260 (2001). (Pubitemid 33706003)
30. Groh, V. et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93, 12445-12450 (1996). (Pubitemid 26367163)
31. Nakamura, Y. The BioBank Japan Project. Clin. Adv. Hematol. Oncol. 5, 696-697 (2007). (Pubitemid 351699412)
32. Yamaguchi-Kabata, Y. et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am. J. Hum. Genet. 83, 445-456 (2008).
33. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007). (Pubitemid 47330214)
34. Frazer, K.A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861 (2007). (Pubitemid 47598626)
35. Breslow, N. & Day, N. Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci. Publ. 1-406 (1987).
36. Tsukiyama-Kohara, K. et al. A second group of hepatitis C viruses. Virus Genes 5, 243-254 (1991).
37. Simmonds, P. et al. Identifcation of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J. Gen. Virol. 75, 1053-1061 (1994).
38. Scott, L.J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345 (2007). (Pubitemid 46871655)
39. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005). (Pubitemid 40202029)
40. Yuan, H.Y. et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 34, W635-W641 (2006).